- Emphasize the importance of regulatory bodies adapting to facilitate swift approvals for evolving wound care innovations, aligning standards with technology advancements.
- Explore the mutually beneficial link between regulatory backing and industry growth
Julie Morabito
Assistant Director, Division of Infection Control and Plastic and Reconstructive Surgery at FDA’s Center for Devices and Radiological Health (CDRH). (Plastic Surgery Skin and Wound Devices Team).
Video Interview - Gavin Proudly
- Investigate cutting-edge wound care tech and personalized medicine.
- Navigate changing regulations, prioritize standardized protocols, and promote patient engagement through education and home-based care.
- Evaluate economic impacts, enhance reimbursement models, and address accessibility challenges
Kevin Richardson
Emma Wright
Emma is an industry professional with 25 years of experience in medical devices in both start-up and international companies, based in UK, US and most recently in Sweden. Her career has been focused on the development and commercialisation of devices in wound care, reconstructive surgery and orthopedics with a specific interest in products that actively promote tissue repair. In the last 10 years Emma has led clinical, medical and health economic teams with responsibility for clinical evidence generation, professional education, medical affairs and health economics.